Treatment for pharyngeal gonorrhoea under threat.
暂无分享,去创建一个
[1] M. Unemo,et al. Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018 , 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[2] Monica Lahra,et al. Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin. , 2018, The Lancet. Infectious diseases.
[3] M. Unemo,et al. Multidrug-resistant Neisseria gonorrhoeae failing treatment with ceftriaxone and doxycycline in France, November 2017. , 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[4] W. Demczuk,et al. Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain , 2018, Emerging infectious diseases.
[5] P. Barreiro. Hot News: Sexually Transmitted Infections on the Rise in PrEP Users. , 2018, AIDS reviews.
[6] John Paul,et al. Whole genome sequencing of Neisseria gonorrhoeae reveals transmission clusters involving patients of mixed HIV serostatus , 2017, Sexually Transmitted Infections.
[7] M. Gambhir,et al. Neisseria gonorrhoeae Transmission Among Men Who Have Sex With Men: An Anatomical Site-Specific Mathematical Model Evaluating the Potential Preventive Impact of Mouthwash , 2017, Sexually transmitted diseases.
[8] J. Hocking,et al. Oral and anal sex are key to sustaining gonorrhoea at endemic levels in MSM populations: a mathematical model , 2015, Sexually Transmitted Infections.
[9] Julian Parkhill,et al. Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study , 2014, The Lancet. Infectious diseases.